The combined differential tumor versus normal tissue expression of two genes and their vectorial summation correlated with the PFS of three patients treated with afatinib as monotherapy (Table 1 and Supplemental Fig. 2d–f): NRG4 and NRG2 (r = −1 p = 8.4E−04). The gene discussed is NRG2; the disease is neoplasm.